Nuvectis Pharma's total assets for Q3 2024 were $17.31M, a decrease of -5.42% from the previous quarter. NVCT total liabilities were $6.32M for the fiscal quarter, a 9.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.